FindTrial
Sign In

EFFECTIVENESS OF BUPRENORPHINE TRANSDERMAL PATCH FOR POSTOPERATIVE PAIN RELIEF IN ARTHROSCOPIC KNEE SURGERIES

EFFICACY OF BUPRENORPHINE TRANSDERMAL PATCH FOR POSTOPERATIVE ANALGESIA IN ARTHROSCOPIC KNEE SURGERIES

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/037779
Enrollment
60
Registered
2021-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: S834- Sprain of collateral ligament of knee Health Condition 3: S835- Sprain of cruciate ligament of knee

Interventions

Intervention1: BUPRENORPHINE TRANSDERMAL PATCH 5 MG: Group(B)-30 cases , Buprenorphine transdermal patch of 5mg will be applied for 7 days. Control Intervention1: PLACEBO PATCH: Group (P)- 30 cases, P

Sponsors

DR D Y PATIL MEDICAL COLLEGE AND HOSPITAL AND RESEARCH CENTRE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA grade I or II fit patients. 2. Ages between 18-60 years of either gender. 3. Patients posted for arthroscopic surgery under spinal anesthesia. 4. Hemodynamically stable patients with all routine investigations within normal limitswithout any other co-morbidities. 5. Patients who are not on any cardiac related drugs. 6. Availability of informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with ASA physical status 3 or more. 2. Patients below 18 years and above 60 years of age. 3. Patients posted for emergency procedures. 4. Patients with major neurological, cardiac, respiratory, metabolic, renal, hepatic disease with coagulation abnormalities. 5. Patients contraindicated for spinal anaesthesia 6. Patients with cardiac co-morbidities. 7. Patients with skin allergies. 8. Patient refusal.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of buprenorphine transdermal patch for post operative analgesia in arthroscopic knee surgeries.Timepoint: 5 MONTHS—

Secondary

MeasureTime frame
Duration of post operative analgesia. Adverse effects of the study drug , if any and its management Timepoint: 5 MONTHS—

Countries

India

Contacts

Public ContactGANDRU VISHNU TEJA

PROFESSOR

drsonalkhatavkar@yahoo.co.in9820434472

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026